Takeda Pharmaceutical EBITDA Margin 2010-2024 | TAK

Takeda Pharmaceutical ebitda margin for the quarter ending September 30, 2024 was 21.46%.

  • Takeda Pharmaceutical average ebitda margin for 2023 was 26.85%, a 0.44% decline from 2022.
  • Takeda Pharmaceutical average ebitda margin for 2022 was 26.97%, a 71.44% decline from 2021.
  • Takeda Pharmaceutical average ebitda margin for 2021 was 94.42%, a 280.88% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Takeda Pharmaceutical EBITDA Margin 2010-2024 | TAK

  • Takeda Pharmaceutical average ebitda margin for 2023 was 26.85%, a 0.44% decline from 2022.
  • Takeda Pharmaceutical average ebitda margin for 2022 was 26.97%, a 71.44% decline from 2021.
  • Takeda Pharmaceutical average ebitda margin for 2021 was 94.42%, a 280.88% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.